UnknownNot applicableNCT00724802

Oral Glyceryl Triacetate (GTA) in Newborns With Canavan

Studying Canavan disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Shaare Zedek Medical Center
Principal Investigator
Gheona Alterescu, M.D.
Shaare Zedek Medical Center
Intervention
GTA (Glyceryl triacetate)(dietary_supplement)
Enrollment
1 enrolled
Eligibility
All sexes
Timeline
2008

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00724802 on ClinicalTrials.gov

Other trials for Canavan disease

Additional recruiting or active studies for the same condition.

See all trials for Canavan disease →

← Back to all trials